NCT01696175

Brief Summary

Observational multicentre cohort study. Children admitted to a Dutch PICU are studied for lactate levels and ScvO2. Children instrumented with arterial and central venous catheters are included within the first 12 hours after admittance.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 28, 2012

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

October 2, 2017

Status Verified

September 1, 2017

Enrollment Period

4.6 years

First QC Date

September 26, 2012

Last Update Submit

September 28, 2017

Conditions

Keywords

ScvO2venousoxymetrylactatechildrenPICUAdmission parameters of shock

Outcome Measures

Primary Outcomes (1)

  • What is the incidence of a decreased ScvO2 and or a raised lactate level in children admitted to Dutch PICU's in the first 24 hours after admission to the PICU

    What is the incidence of a decreased ScvO2 and or a raised lactate level in children admitted to Dutch PICU's in the first 24 hours after admission to the PICU

    first 24 hours after admission

Study Arms (1)

PICU admittance

Children equipped with an arterial and a central venous catheter within 12 hours after admittance to a Dutch PICU

Eligibility Criteria

Age1 Week - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Al children admitted to a PICU \<= 16 years equipped with an arterial and central venous catheter in situ at admission or inserted within \< 12 hours after admission to the PICU.

You may qualify if:

  • Al children admitted to a PICU \<= 16 years equipped with an arterial and central venous catheter in situ at admission or inserted within \< 12 hours after admission to the PICU

You may not qualify if:

  • Patients without an arterial or central venous catheter \> 12 hours after of admission
  • Patients with a known underlying metabolic disorder causing an elevated lactate level
  • Patients with asthma and therapy (nebulized or intravenous) with salbutamol.
  • Patients with an intoxication causing elevated lactate levels
  • Premature children (\<38 weeks GA)
  • Patients on ECMO

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RUNMC

Nijmegen, Netherlands

Location

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical director pediatric intensive care unit

Study Record Dates

First Submitted

September 26, 2012

First Posted

September 28, 2012

Study Start

September 1, 2012

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

October 2, 2017

Record last verified: 2017-09

Locations